Topamax Lawsuit
March 22nd, 2011
Topamax is an anti-convulsant used to treat epileptic seizures in children and adults, and is also prescribed to prevent migraine headaches. Topamax can result in cleft lip or cleft palate – birth defects that occur when the lip or palate fail to completely fuse together. The defect can result in a small, notched lip or in extreme cases, an open groove that extends from the roof of the mouth to the nose.
A 2008 scientific study, published in Neurology Magazine, showed that taking Topamax significantly increases the risk of birth defects. The published study reviewed 203 pregnancies – the rate of oral clefts observed was 11 times more prevalent than the normal rate. Due to these and other serious side effects, the United States Food and Drug Administration (FDA) issued a new warning for patients taking Topamax. The new warning, issued March 4, 2011, was raised to Category D, which means there is positive evidence of human fetal risk.
At O’Hanlon, McCollom & Demerath, our attorneys understand that your child’s injuries may not be your fault – instead, possibly a dangerous side effect of Topamax. Our expertise and experience, combined with our highly trained staff, make us uniquely well-equipped to handle even the most complex products liability claims.